Skip to content

Exagen Inc. XGN Change in AP

Change in AP at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
-$138.7M+6.0%
Quest Diagnostics logo
Quest DiagnosticsDGX
-$12M+77.4%
Vor Biopharma logo
Vor BiopharmaVOR
-$9.1M-563%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$219K-45.0%
CareDx logo
CareDxCDNA
-$338K-190%
Revvity logo
RevvityRVTY
-$13.74M-255%

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
Enterprise value$117.78M-20.3%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp
FCF margin-27.5%

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s change in AP?
Exagen Inc. (XGN) reported change in AP of -$41K in Q1 2026.
How has Exagen Inc.'s change in AP changed year-over-year?
Exagen Inc.'s change in AP decreased by 117.7% year-over-year, from $231K to -$41K.
What is the long-term trend for Exagen Inc.'s change in AP?
Over 2 years (2023 to 2025), Exagen Inc.'s change in AP has grown at a -20.8% compound annual growth rate (CAGR), from $67K to $42K.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.